Medical marijuana is now legal in Mississippi for patients suffering from debilitating conditions after Governor Tate Reeves signed a bill into law on Wednesday. This legislative move adds Mississippi as the 37th state to legalize medical cannabis, a significant development in the state’s approach to patient care and cannabis regulation.
In his statement, Gov. Reeves acknowledged the potential benefits of medical marijuana, stating, “There is no doubt that there are individuals in our state who could do significantly better if they had access to medically prescribed doses of cannabis.” He also expressed concerns over the desire for a recreational marijuana program, warning that it could lead to more societal issues.
Eligibility and Regulations
The new law permits eligible patients with conditions such as cancer, Parkinson’s disease, Huntington’s disease, AIDS, Crohn’s disease, and autism to purchase medical marijuana. Patients must obtain a certification following an in-person examination by a qualified medical professional and receive a registry identification card from the Mississippi Department of Health.
Strict regulations accompany the implementation of medical cannabis. Dispensaries are prohibited from operating within 1,000 feet of schools, churches, or childcare facilities unless a waiver is obtained. The law also prevents discrimination against cardholders by schools, landlords, and employers while allowing certain restrictions at healthcare facilities like hospitals and nursing homes. Schools and childcare facilities can administer medical cannabis similarly to medical prescriptions.
A Turbulent Legislative Journey
The path to this legislation has been rocky. In November 2020, a comparable bill had overwhelming voter support but was later invalidated by the state Supreme Court due to ballot initiative issues. It took further legislative action and negotiation over purchasing limits for the bill to be passed.
While Gov. Reeves described the bill as imperfect, he highlighted the limitations on marijuana purchases as a positive factor, suggesting it could lead to “hundreds of millions of fewer joints on the streets.”
Jax James, NORML’s State Policies Manager, called the new law “long overdue,” emphasizing that the majority of voters favored this change over a year ago, highlighting a delay in the will of the people.
This legal shift in Mississippi not only signifies a change in healthcare access for patients but also presents opportunities for growth in the cannabis industry, potentially shaping the state’s market outlook and regulatory landscape moving forward.
